mGluR2 NAMs (DomainTherapeutics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamemGluR2 NAMs (DomainTherapeutics)
Drug Alias Namemetabotropic glutamate receptor 2 modulators (DomainTherapeutics)mGluR2 NAMs (DomainTherapeutics)DT-2442DT-2228
ClassificationSmall molecules
Mechanisms of ActionMetabotropic glutamate receptor 2 modulatorsNeuroprotectants
TargetsMetabotropic glutamate receptor 2
Therapy Area/IndicationsDepressionAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDomain Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDomain Therapeutics SA
Active IndicationsN/A
Inactive IndicationsDepressionAlzheimer DiseaseParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A